AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6486080
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (25 mg, two daily doses)
Trial: 24777150
Drug: Esomeprazole IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole IV bolus at a dose of 80 mg plus infusion at 8 mg/h for 72 h and oral placebo every 12 h (IVP group)
Trial: 24777150
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral esomeprazole at a dose of 40 mg every 12 h (ORP group)
Trial: 11300382
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose L-arginine (n=10)
Trial: 11300382
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose L-arginine (n=10)
Trial: 3145948
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of flurazepam taken the night before surgery
Trial: 28679180
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 suppository/day for 1 month)
Trial: 18186996
Drug: Bulb syringe
RxNorm normalized name: Bulb Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bulb syringe self-treatment
Trial: 14693310
Drug: Intramuscular interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular interferon beta‐1a (IFNβ‐1a) 30 μg IM once weekly
Trial: 1749978
Drug: Intravenous narcotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous narcotics
Trial: 6195981
Drug: Hydroxyethyl starch
RxNorm normalized name: Hydroxyethyl starch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl starch (HES) 1,000 ml
Trial: 6195981
Drug: 25% albumin
RxNorm normalized name: Flexbumin 25% Albumin (Human) Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% albumin 200 ml
Trial: 18257182
Drug: Acup‐moxibustion treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acup‐moxibustion treatment
Trial: 15766996
Drug: Rasagiline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline (1 mg once daily)
Trial: 15766996
Drug: Entacapone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (200 mg with every levodopa dose)
Trial: 2040104
Drug: Piroxicam 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 0.5% gel (5 mg q.i.d.)
Trial: 7325344
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of peridural anaesthesia and neuroleptanalgesia (PDA/NLA)
Trial: 19099547
Drug: 0.5-2% chitin-glucan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5-2% chitin-glucan applied twice daily
Trial: 19099547
Drug: 1.5% chitin-glucan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5% chitin-glucan formulation applied twice daily
Trial: 11967499
Drug: Raloxifene 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 150 mg
Trial: 1723455
Drug: Nitrendipine 10
RxNorm normalized name: nitrendipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 10 mg once daily
Trial: 7472173
Drug: Phenobarbital (Luminal)
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital (Luminal) 15 mg/kg intramuscularly
Trial: 7472173
Drug: Phenobarbital (Luminal)
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital (Luminal) 5 mg/kg orally or intramuscularly
Trial: 28818050
Drug: Probiotic administration
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic administration
Trial: 23380438
Drug: PRM‐151 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRM‐151 (10 mg/kg)
Trial: 18832751
Drug: rHDL (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHDL (80 mg/kg given over 4 hours)
Trial: 11304763
Drug: Topotecan (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan (1.5 mg/m²/d for 5 days, every 3 weeks)
Trial: 23566071
Drug: 5% sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% sterile topical royal jelly
Trial: 14595527
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of SSRI drugs (intervention group, n=35)
Trial: 14595527
Drug: No change
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No change in treatment (control group, n=35)
Trial: 11110743
Drug: Multifaceted intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multifaceted intervention promoting early switch from intravenous to oral acetaminophen
Trial: 1326846
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) 2500 anti‐XaU once daily
Trial: 1326846
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UH) 5000 anti‐XaU twice daily
Trial: 3890130
Drug: L-carnitine, 2
RxNorm normalized name: L-Carnitine, 250 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine, 2 g i.v. three times a week
Trial: 24607003
Drug: Investigational vaccine
RxNorm normalized name: INVESTIGATIONAL VACCINES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational vaccine formulations containing dPly alone (10 or 30 μg) or both dPly and PhtD (10 or 30 μg each)
Trial: 11850760
Drug: Single drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drugs (amphetamine, benzphetamine, fenfluramine, sibutramine)
Trial: 11850760
Drug: Combination drugs
RxNorm normalized name: combination drugs used in erectile dysfunction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination drugs
Trial: 11850760
Drug: Overall medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall medications studied
Trial: 3530226
Drug: Semisynthetic human
RxNorm normalized name: INSULIN,NPH,HUMAN/SEMISYNTHETIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semisynthetic human insulin (Novo)
Trial: 3530226
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified porcine insulin (Monocomponent)
Trial: 28972854
Drug: 500 mL
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mL of milk (MILK)
Trial: 10958249
Drug: Bromocriptine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine 1.25 mg
Trial: 12655514
Drug: One course
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One course of perioperative chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil
Trial: 7744132
Drug: Nimesulide 50
RxNorm normalized name: nimesulide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 50 mg bd
Trial: 2661700
Drug: Ticlopidine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (250 mg twice per day)
Trial: 1097490
Drug: Gerovital H3
RxNorm normalized name: Vitamin H3
DrugBank: Procaine (DB00721)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gerovital H3 (5 ml injection, 3 times a week for first 6 weeks, then 10 ml injection for next 6 weeks)
Trial: 28916443
Drug: AQ-13 (638.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AQ-13 (638.50 mg on days 1 and 2, 319.25 mg on day 3)
Trial: 28916443
Drug: Artemether plus
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Artemether plus lumefantrine (80 mg artemether and 480 mg lumefantrine twice daily for 3 days)
Trial: 17935647
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron supplements (control)
Trial: 23574579
Drug: LMWH followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LMWH followed by warfarin
Trial: 18942523
Drug: LMWH as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMWH as a bridge therapy
Trial: 14555312
Drug: Certoparin (fixed,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Certoparin (fixed, body-weight-independent dose of 8,000 IU b.i.d. for 8.6 days)
Trial: 14555312
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (IV, adjusted to an 1.5 to 3.0-fold prolongation of the aPTT for 12.0 days)
Trial: 10703934
Drug: HRT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT group (n = 145) received a sequential combination of 2 mg estradiol valerate and 1 mg CPA with or without vitamin D3, 100‐300 IU + 500 mg calcium lactate/day (equal to 93 mg Ca2+)
Trial: 10703934
Drug: Non-HRT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-HRT group (n = 177) received calcium lactate, 500 mg alone or in combination with vitamin D3, 100‐300 IU/day
Trial: 8356542
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of methohexital
Trial: 22928495
Drug: Guaiazulene (GA)
RxNorm normalized name: guaiazulene
DrugBank: Guaiazulen (DB13329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guaiazulene (GA) containing local pomade (0.05 g/100 g)
Trial: 22928495
Drug: Extended antifungal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended antifungal treatment (Control)
Trial: 20200165
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for silent GERD
Trial: 16373898
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day ranirestat
Trial: 16373898
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day ranirestat
Trial: 10926393
Drug: Alcoholic-hand-gel regimen
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcoholic-hand-gel regimen
Trial: 1997044
Drug: Morphine sulphate
RxNorm normalized name: Morphine sulphate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulphate 120 micrograms kg‐1
Trial: 29848335
Drug: Life skills
RxNorm normalized name: Life-O-Gen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Life skills building education and multiple micronutrient supplementation (UNIMMAP composition), provided bi-monthly and twice-weekly respectively.
Trial: 24496740
Drug: Cost analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost analysis of disposable spray tips
Trial: 19619690
Drug: 4 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g/d prescription omega-3-acid ethyl esters (P-OM3)
Trial: 23098346
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg / Hydrochlorothiazide 12.5 mg
Trial: 23098346
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg / Hydrochlorothiazide 25 mg
Trial: 1608850
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg phenytoin
Trial: 1608850
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg phenytoin
Trial: 28668573
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of whole-virus H7N9 vaccine (30μg HA with aluminum hydroxide adjuvant)
Trial: 28668573
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of whole-virus H7N9 vaccine (15μg HA)
Trial: 28668573
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of whole-virus H7N9 vaccine (30μg HA without adjuvant)
Trial: 12641688
Drug: Tramadol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (1 mg.kg(‐1))
Trial: 2941291
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg ciprofloxacin (n = 85)
Trial: 26892847
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy (MBCT) with discontinuation of mADM (n=128)
Trial: 26892847
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy (MBCT) + maintenance antidepressant medication (mADM) (n=121)
Trial: 20129568
Drug: RIPC and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIPC and morphine
Trial: 16868056
Drug: Behavioral intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Behavioral intervention promoting a diet with 28% energy from total fat, less than 8% from saturated fat, 9% or less from polyunsaturated fat, and less than 75 mg cholesterol per 1000 kcal.
Trial: 10856147
Drug: Inhaled indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled indomethacin (50 mg/d)
Trial: 9126694
Drug: Meropenem (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem (1,000 mg iv every 8 hours)
Trial: 9126694
Drug: Clindamycin (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin (900 mg every 8 hours) plus Tobramycin (5 mg/[kg.d] in three divided doses) iv
Trial: 1493841
Drug: Temazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam (15 mg) plus ethanol (peak blood concentration of 11 mmol.l‐1)
Trial: 6861846
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg p.o.)
Trial: 18520792
Drug: Schedule-dependent low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Schedule-dependent low-dose paclitaxel for radiosensitization
Trial: 12790886
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy (anteromesial temporal lobe resection)
Trial: 10348786
Drug: AZ (5
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: AZ (5 mg/kg/day) alone (ALONE)
Trial: 10348786
Drug: AZ (5
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: AZ (5 mg/kg/day) and ATQ (30 mg/kg/day) simultaneously (SIM)
Trial: 7554041
Drug: Oral tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tamoxifen at 10 mg twice a day
Trial: 7554041
Drug: Percutaneous 4-OH-TAM
RxNorm normalized name: 4-OH-A
DrugBank: Formestane (DB08905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous 4-OH-TAM at 0.5 mg/day
Trial: 7554041
Drug: Percutaneous 4-OH-TAM
RxNorm normalized name: 4-OH-A
DrugBank: Formestane (DB08905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous 4-OH-TAM at 1 mg/day
Trial: 7554041
Drug: Percutaneous 4-OH-TAM
RxNorm normalized name: 4-OH-A
DrugBank: Formestane (DB08905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous 4-OH-TAM at 1 mg/day to a large cutaneous area excluding the breasts
Trial: 7554041
Drug: Percutaneous 4-OH-TAM
RxNorm normalized name: 4-OH-A
DrugBank: Formestane (DB08905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous 4-OH-TAM at 2 mg/day to a large skin area excluding the breasts
Trial: 30045346
Drug: 12 months
RxNorm normalized name: Elecare HMO 0-12 Months
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 months of anti tubercular therapy (ATT)
Trial: 2523665
Drug: Isradipine (1.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (1.25, 2.5, and 5.0 mg twice daily)
Trial: 66240
Drug: Oral oxymorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxymorphone
Trial: 67128
Drug: Intramuscular oxymorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular oxymorphone
Trial: 6730874
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine
Trial: 31350753
Drug: Placebo beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo beverage (PB) - kCal: 5, Na: 35 mg
Trial: 9549168
Drug: Doxazosin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (4 mg daily)
Trial: 7522395
Drug: G-CSF 10
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF 10 micrograms/kg
Trial: 7522395
Drug: G-CSF 5
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF 5 micrograms/kg
Trial: 3139705
Drug: Control preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control preparation containing polysaccharides only (24 volunteers)
Trial: 29265454
Drug: Non-surgical periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical periodontal treatment (oral hygiene instructions + scaling and root planing using ultrasound and Gracey curettes)
Trial: 29265454
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral hygiene instructions + supragingival removal of plaque and calculus using ultrasound)
Trial: 27569442
Drug: MAP (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAP (cisplatin 120 mg/m2, doxorubicin 37.5 mg/m2 on days 1 and 2, high-dose methotrexate 12 g/m2)
Trial: 25405132
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg elemental magnesium (as magnesium sulfate ‐MgSo4‐) daily for 3 months
Trial: 19083405
Drug: Creatine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine (4 g/d for 2 years)
Trial: 14560218
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 325 mg daily
Trial: 14560218
Drug: Clopidogrel (Clop)
DrugBank: Clopidogrel (DB00758)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Clopidogrel (Clop) 75 mg daily
Trial: 14560218
Drug: Cilostazol (Cilo)
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cilostazol (Cilo) 100 mg twice daily
Trial: 8215478
Drug: Granisetron plus
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron plus hydroxyzine hydrochloride (Group G/H)
Trial: 8215478
Drug: Granisetron alone
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron alone (Group G)
Trial: 3691592
Drug: Nicardipine (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (90 mg/day) + Propranolol (120 mg/day)
Trial: 6469425
Drug: Propranolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (120 mg/day)
Trial: 17022378
Drug: Pycnogenol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol (50 mg capsules, 3 times daily for a total of 150 mg daily for 4 weeks)
Trial: 17067979
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no treatment during the observation period)
Trial: 14672470
Drug: Intravenous ampicillin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ampicillin, 2 g every 6 hours, and gentamicin, 1.5 mg/kg every 8 hours, continued until afebrile and asymptomatic for 24 hours (control group)
Trial: 10723818
Drug: Nicotine oral
RxNorm normalized name: nicotine Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine oral inhaler
Trial: 27884360
Drug: Drug-Coated Balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-Coated Balloon (DCB) angioplasty
Trial: 26689885
Drug: Subcutaneous unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous unfractionated heparin 5000 units three-times a day
Trial: 26689885
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of unfractionated heparin 625 IU/h
Trial: 22525915
Drug: Paracervical block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracervical block (2 mL 1% buffered lidocaine at tenaculum site + 18 mL at four sites)
Trial: 22525915
Drug: Sham (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham (no injection)
Trial: 18377682
Drug: FOS (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS (10 g once daily for 5 weeks)
Trial: 18377682
Drug: Maltodextrin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltodextrin (10 g once daily for 2 weeks during run-in phase)
Trial: 14708414
Drug: Acetaminophen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (20 mg/kg) administered rectally if pain score > 3/10
Trial: 3552358
Drug: Verapamil (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (450 +/- 30 mg/day)
Trial: 29401192
Drug: Multi-ingredient preworkout
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-ingredient preworkout supplement (SUP)
Trial: 9144347
Drug: TIB, tibolone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIB, tibolone, 2.5 mg/day continuously, orally
Trial: 9144347
Drug: PO, peroral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PO, peroral E2, 2 mg/day continuously, plus sequential oral dydrogesterone (DYD), 10 mg/day, for 14 days of a 28-day cycle